Meditech Spine Gains FDA Clearance for CURE OPEL-L (S)

By Julie A. Vetalice

Meditech Spine Gains FDA Clearance for CURE OPEL-L (S)

Meditech Spine received FDA 510(k) clearance to market the CURE™ Opel-L (S) system. The new lumbar plate option that expands the previously-cleared CURE™ LP system (pictured above) and complements the Talos®-A (HA) Interbody device.

The addition of the Opel-L (S) plating option paired with the Talos interbody offers maximal ability to accommodate different patient anatomies. The new system features increased screw angulation and repeatable, precise A/P alignment with an optional All-in-One drill guide during placement.

Meditech is adding and launching hyper-lordotic sizes to its existing Talos-A (HA) line of osteoconductive PEEK-OPTIMA® HA Enhanced ALIF implants. Initial launch for this integrated system is slated for 3Q20 and is the first of three anticipated clearances this year for the company.

Meditech continues its relationship with CURE International, the namesake of the CURE ACP, an organization that serves children with physical disabilities in underserved areas. A portion of proceeds from the sale of every plate will support treatment of patients who are in need of surgical care.